Comparative Efficacy and Safety of Extended Versus Standard Interval Dosing of Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients: A Multicenter Analysis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Meral Seferoğlu, Abdulkadir Tunç, Ali Özhan Sıvacı, Bilge Piri Çınar, Sena Destan Bünül, Özlem Ethemoğlu, Ülgen Yalaz Tekan, Mehmet Fatih Yetkin
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	CNS Neuroscience & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet